Radiation exposure compared for lumbosacral epidural approaches

January 24, 2014
Radiation exposure compared for lumbosacral epidural approaches

(HealthDay)—For fluoroscopy-guided lumbosacral epidural steroid injections (ESIs), the kerma-area product (KAP) of transforaminal ESI is less than that of caudal ESI, after adjustment for length of fluoroscopy time, according to a study published in the February issue of the Journal of Spinal Disorders & Techniques.

Seon-Jeong Kim, M.D., from the University of Ulsan College of Medicine in Seoul, South Korea, and colleagues assessed and compared radiation exposure caused by the fluoroscopy-guided transforaminal and caudal approaches of lumbosacral ESI. Participants included 228 patients who received lumbosacral ESI (181 transforaminal and 47 caudal). In all patients, the KAP and fluoroscopy time were recorded.

The researchers found that the KAP varied from 3.02 to 1,048.2 µGy m² (mean, 101.7 µGy m²) for transforaminal ESI, and from 16.0 to 604.5 µGy m² (mean, 101.8 µGy m²) for caudal ESI. For transforaminal and caudal ESI, the fluoroscopy time was 11 to 161 seconds (mean, 36.0 seconds) and 4 to 678 seconds (mean, 18.2 seconds), respectively, with significantly longer fluoroscopy time for transforaminal ESI (P = 0.000). There was a positive correlation between KAP and fluoroscopy time for each approach (P < 0.001). After adjustment for fluoroscopy time, KAP was less in transforaminal versus caudal ESI (P = 0.000).

"KAP of transforaminal ESI was less than that of the caudal ESI, after being corrected for the length of time," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Pedicle breach rate 6.2 percent with 2D fluoroscopy

June 21, 2012

(HealthDay) -- A two-dimensional (2D) fluoroscopic technique is safe for percutaneous placement of pedicle screws during transforaminal lumbar interbody fusion (TLIF), with a pedicle breach rate of 6.2 percent, according ...

Etanercept cuts sciatic pain from lumbar disc herniation

November 1, 2013

(HealthDay)—Compared with placebo, transforaminal injections of etanercept provide relief from leg and back pain in patients with symptomatic lumbar disc herniation (LDH), according to research published in the Nov. 1 issue ...

Recommended for you

Experimental MERS vaccine shows promise in animal studies

July 28, 2015

A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines. ...

Can social isolation fuel epidemics?

July 21, 2015

Conventional wisdom has it that the more people stay within their own social groups and avoid others, the less likely it is small disease outbreaks turn into full-blown epidemics. But the conventional wisdom is wrong, according ...

Lack of knowledge on animal disease leaves humans at risk

July 20, 2015

Researchers from the University of Sydney have painted the most detailed picture to date of major infectious diseases shared between wildlife and livestock, and found a huge gap in knowledge about diseases which could spread ...

IBD genetically similar in Europeans and non-Europeans

July 20, 2015

The first genetic study of inflammatory bowel disease (IBD) to include individuals from diverse populations has shown that the regions of the genome underlying the disease are consistent around the world. This study, conducted ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.